The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia

被引：0

作者：

Morabito, Fortunato ^{[1
]}

Tripepi, Giovanni ^{[2
]}

Mauro, Francesca Romana ^{[3
]}

Laurenti, Luca ^{[4
]}

Reda, Gianluigi ^{[5
,6
]}

Moia, Riccardo ^{[7
]}

Condoluci, Adalgisa ^{[8
,9
]}

Vincelli, Iolanda ^{[10
]}

Chiarenza, Annalisa ^{[11
]}

Vigna, Ernesto ^{[12
]}

Martino, Enrica Antonia ^{[12
]}

Bruzzese, Antonella

Mezzatesta, Sabrina ^{[2
]}

Laureana, Roberta ^{[13
]}

Cutrona, Giovanna ^{[14
]}

Di Raimondo, Francesco

Fronza, Gilberto ^{[15
]}

Zucchetto, Antonella ^{[16
]}

Bomben, Riccardo ^{[16
]}

Rossi, Francesca Maria ^{[16
]}

Olivieri, Jacopo ^{[17
]}

Zaja, Francesco ^{[18
]}

Rossi, Davide ^{[8
,9
]}

Gaidano, Gianluca ^{[7
]}

Del Principe, Maria Ilaria ^{[13
]}

Ilariucci, Fiorella ^{[19
]}

Del Poeta, Giovanni ^{[13
]}

Ferrarini, Manlio ^{[14
]}

Neri, Antonino ^{[20
]}

Gattei, Valter ^{[16
]}

Gentile, Massimo ^{[12
,21
]}

机构：

[1] AO ASP Cosenza, Biotechnol Res Unit, Aprigliano, I-87100 Cosenza, Italy

[2] CNR, Ist Fisiol Clin CNR, Reggio Di Calabria, Italy

[3] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Rome, Italy

[4] Catholic Univ Hosp A Gemelli Rome, Dept Hematol, Rome, Italy

[5] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy

[6] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Hematol CTMO, Milan, Italy

[7] Univ Piemonte Orientale, Dept Translat Med, Div Haematol, Novara, Italy

[8] Oncol Inst Southern Switzerland, Bellinzona, Switzerland

[9] Inst Oncol Res, Bellinzona, Switzerland

[10] Hematol Unit Reggio Calabria, Reggio Di Calabria, Italy

[11] Univ Catania, Osped Ferrarotto, Div Ematol, Catania, Italy

[12] AO Cosenza, Dept Oncohematol, Hematol Unit, Cosenza, Italy

[13] Univ Roma Tor Vergata, Dipartimento Biomed & Prevenz, Ematol, Rome, Italy

[14] Osped Policlin San Martino IRCCS, UO Mol Pathol, Genoa, Italy

[15] IRCCS Osped Policlin San Martino, Mutagenesis & Canc Prevent Unit, Genoa, Italy

[16] Ctr Riferimento Oncol Aviano CRO IRCCS, Clin & Expt Onco Hematol Unit, Aviano, Italy

[17] Azienda Osped Univ S Maria Misericordia, Ctr Trapianti & Terapie Cellulari, Clin Ematol, Udine, Italy

[18] Univ Trieste, Haematol, Trieste, Italy

[19] Azienda USL IRCCS Reggio Emilia, Hematol Unit, Reggio Emilia, Italy

[20] Azienda USL IRCCS Reggio Emilia, Sci Directorate, Reggio Emilia, Italy

[21] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 07期

基金：

瑞士国家科学基金会; 欧洲研究理事会;

关键词：

PROGRESSION; RISK;

D O I：

10.1002/ajh.26927

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E157 / E160

页数：4

共 50 条

[31] Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival
Visco, Carlo
Falisi, Erika
Young, Ken H.
Pascarella, Michela
Perbellini, Omar
Carli, Giuseppe
Novella, Elisabetta
Rossi, Davide
Giaretta, Ilaria
Cavallini, Chiara
Scupoli, Maria Teresa
De Rossi, Anita
D'Amore, Emanuele Stefano Giovanni
Rassu, Mario
Gaidano, Gianluca
Pizzolo, Giovanni
Ambrosetti, Achille
Rodeghiero, Francesco
ONCOTARGET, 2015, 6 (21) : 18653 - 18663
[32] RELATIONSHIP BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA
Beauchemin, C.
Johnston, J. B.
Lapierre, M.
Aissa, F.
Lachaine, J.
ANNALS OF ONCOLOGY, 2012, 23 : 350 - 350
[33] RELATIONSHIP BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA
Beauchemin, C.
Johnston, J.
Lapierre, M. E.
Aissa, F.
Lachaine, J.
VALUE IN HEALTH, 2012, 15 (07) : A414 - A415
[34] CD49d Is the Strongest Flow Cytometry-Based Predictor of Overall Survival in Chronic Lymphocytic Leukemia
Bulian, Pietro
Shanafelt, Tait D.
Fegan, Chris
Zucchetto, Antonella
Cro, Lilla
Nueckel, Holger
Baldini, Luca
Kurtova, Antonina V.
Ferrajoli, Alessandra
Burger, Jan A.
Gaidano, Gianluca
Del Poeta, Giovanni
Pepper, Chris
Rossi, Davide
Gattei, Valter
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (09) : 897 - +
[35] CD49d Is The Strongest Flow Cytometry-Based Predictor Of Overall Survival In Chronic Lymphocytic Leukemia
Bulian, Pietro
Shanafelt, Tait D.
Fegan, Chris
Zucchetto, Antonella
Cro, Lilla
Nuckel, Holger
Baldini, Luca
Kurtova, Antonina
Ferrajoli, Alessandra
Burger, Jan A.
Gaidano, Gianluca
Del Poeta, Giovanni
Pepper, Chris
Rossi, Davide
Gattei, Valter
BLOOD, 2013, 122 (21)
[36] mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia
Kontos, Christos K.
Papageorgiou, Sotirios G.
Diamantopoulos, Marios A.
Scorilas, Andreas
Bazani, Efthimia
Vasilatou, Diamantina
Gkontopoulos, Konstantinos
Glezou, Eirini
Stavroulaki, Georgia
Dimitriadis, George
Pappa, Vasiliki
LEUKEMIA RESEARCH, 2017, 53 : 65 - 73
[37] IMPACT OF CLINICAL AND BIOLOGICAL VARIABLES ON TIME TO FIRST TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA
Giordano, A.
Curci, P.
Rizzi, R.
Perrone, T.
Cimmino, A.
Mestice, A.
Nardelli, G.
Daraia, B.
Gagliardi, V. P.
Albano, F.
Specchia, G.
HAEMATOLOGICA, 2015, 100 : 681 - 681
[38] Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: identifying risk factors to help guide treatment selection
Bantilan, Kurt S.
Kay, Neil E.
Parikh, Sameer A.
Rabe, Kari G.
Call, Timothy G.
Leis, Jose F.
Ding, Wei
Slager, Susan L.
Soumerai, Jacob D.
Roeker, Lindsey E.
Mato, Anthony
Zelenetz, Andrew D.
LEUKEMIA & LYMPHOMA, 2023, 64 (02) : 300 - 311
[39] LEUKOCYTE DOUBLING TIME IS A USEFUL PREDICTOR OF PROGRESSION-FREE SURVIVAL IN CHRONIC LYMPHOCYTIC-LEUKEMIA
AXDORPH, U
NILSSON, BI
NILSSON, BR
BJORKHOLM, M
JOURNAL OF INTERNAL MEDICINE, 1995, 237 (02) : 205 - 209
[40] CONSTITUTIVE LEVELS OF PHOSPHORYLATED ERK 1&2 PREDICT OVERALL SURVIVAL AND TIME TO FIRST TREATMENT IN CHRONIC LYMPHOCYTIC LEUKAEMIA
Bailey, R.
Eagle, L.
Pointon, J.
Brathwaite, R.
Abbott, J.
Evans, P.
Greenman, J.
Cawkwell, L.
Allsup, D.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 45 - 45

← 1 2 3 4 5 →